Sign in
  • Home
  • Internet News
  • Biotech News
  • Superbug News – CoronaVirus Watch List
  • Research
  • Conferences
    • Technology Conferences
    • Biotech Conferences
  • More Finance Channels
    • BDC Fund Stocks
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Stand Down – Wall Street Bears
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
Thursday, January 28, 2021
  • Sign in / Join
  • Contact Us
  • Featured News
  • Free Weekly Newsletter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Internet | Biotech Stock Review
  • Home
  • Internet News
  • Biotech News
  • Superbug News – CoronaVirus Watch List
  • Research
  • Conferences
    • Technology Conferences
    • Biotech Conferences
  • More Finance Channels
    • BDC Fund Stocks
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Stand Down – Wall Street Bears
Home All News Stand Down. Stand Down X: Peter Shiff, “We Have Run Out of Road, to...
  • All News
  • Stand Down.

Stand Down X: Peter Shiff, “We Have Run Out of Road, to Kick the Can.”

By
Editor / Curator
-
May 19, 2020
Facebook
Twitter
Google+
Pinterest
Linkedin
Email

    RELATED ARTICLESMORE FROM AUTHOR

    Citius, Biotech Stock Review
    2020 Watch List

    Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

    Mitesco, Biotech Stock Review, roland rick perry
    2020 Watch List

    Short Squeeze Mania.

    ENDRA, Biotech Stock Review
    Biotech News

    Heads UP: ENDRA Life Science (NDRA) $1.50, up 40% Today.

    Internet Stock Review
    Bitcoin

    Is the Bitcoin Bubble More Fraud Than Frenzy?

    Biotech News

    Make Hay While the Sun Shines. Up 6,400%.

    Internet Stock Review
    Biotech News

    And it’s Official. We Have Another Double. BioSig (BSGM) up 103% in Four Months.

    OMNIQ
    Cybersecurity

    First Zebra (ZBRA) Then Checkpoint (CHKP), OMNIQ (OQMS) Strengthens Product Line-Up.

    Satori Capital. Hapbee
    Telehealth

    Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head Devices.

    Internet Stock Review
    Bitcoin

    And We Have Our First Bitcoin Double.

    Biotech News

    Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.

    Facebook
    Twitter
    Google+
    Pinterest
    Linkedin
    Email
      Previous articleHow CoronaVirus Accelerated the Rise of Telemedicine (CNBC).
      Next articleOrganicell (BPSR) a Triple Since Easter.
      Editor / Curator

      Plan Your Day Wisely

      January 2021
      M T W T F S S
       123
      45678910
      11121314151617
      18192021222324
      25262728293031
      « Dec    

      Learn Investing From Billionaires (Free)

      Our Favorite Hand Sanitizer

      Aphex, Biotech Stock Review

      Institutional Gold Research Report

      Institutional Gold Research

      Latest article

      Citius, Biotech Stock Review

      Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

      2020 Watch List Editor / Curator - January 27, 2021
      The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...
      Mitesco, Biotech Stock Review, roland rick perry

      Short Squeeze Mania.

      2020 Watch List Editor / Curator - January 26, 2021
      Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...

      Video: Pacific Stem Cell

      Stem Cells Editor / Curator - January 24, 2021
      With nearly a third of the US suffering from chronic pain, and over a million patients a year having joint replacements, affordable...
      Revelers.IO Finance Channel
      The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
      Contact us: roland@institutionalanalyst.com
      • Model Portfolio
      • Disclaimer
      • Contact us
      • Write For Us
      © Managed by Revelers.IO Media Group Inc.
      Edit with Live CSS
      Save
      Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.